摘要
目的分析肿瘤标志物联合检测对胆管癌疾病进行诊断的价值.方法选取2019年3月至2021年3月到本院诊治的胆管癌80例患者资料为研究组,同期健康体检人员80例为对照组,所有人员进行肿瘤标志物联合检测、多层螺旋CT检测,观察检测结果.结果检验后,研究组sICAM-1、CA19-9、CYFRA21-1、CA242阳性率均高于对照组,差异具统计学意义(P<0.05);检验后,研究组CA242、CA19-9、CYFRA21-1、sICAM-1浓度均比正常值高,且比对照组高,差异具统计学意义(P<0.05);肿瘤标志物与CT联合检测的准确率91.25%,比单独进行肿瘤标志物检测准确率78.75%、CT检测准确率75.00%高(P<0.05).结论肿瘤标志物联合检测对诊断胆管癌疾病有重要意义.
Objective To analyze the value of combined detection of tumor markers in the diagnosis of cholangiocarcinoma.Methods 80 patients with cholangiocarcinoma in our hospital from March 2019 to March 2021 were selected as the study group,and 80 healthy persons in the same period were selected as the control group.AU personnel performed combined detection of tumor markers and multi-slice spiral CT,and the detection results were observed.Results After the test,the positive rates of sICAM-1,CA19-9,CYFRA21-1 and CA242 in the study group were higher than those in the control group,and the difference was statistically significant(P<0.05).After the test,the concentrations of CA242,CA19-9,CYFRA21-1 and sICAM-1 in the study group were higher than the normal values,and higher than those in the control group,the difference was statistically significant(P<0.05).The accuracy of combined detection of tumor markers and CT was 91.25%,which was higher than that of single detection of tumor markers(78.75%)and CT(75.00%)(P<0.05).Conclusion The combined detection of tumor markers is of great significance in the diagnosis of cholangiocarcinoma.
作者
张成
Zhang Cheng(Laboratory of Shanghai Yangsi hospital,Shanghai 200126,China)
出处
《当代临床医刊》
2022年第2期1-3,共3页
Journal of Contemporary Clinical Medicine
关键词
肿瘤标志物
联合检测
胆管癌
诊断价值
Tumor markers
Combined detection
Cholangiocarcinoma
Diagnostic value
